WHO grade II meningioma: Epidemiology, survival and contribution of postoperative radiotherapy in a multicenter cohort of 88 patients

Neuro-Chirurgie
G PoulenL Bauchet

Abstract

Meningioma is the most common primary intracranial tumor, representing 13-36.6% of all primary central nervous system tumors. Meningiomas are benign in about 90% of cases. World Health Organization (WHO) grade II meningioma is associated with a high rate of recurrence and poorer survival than in grade I. The reference treatment is surgery, which should be as complete as possible. Currently, in grade II, there are no recommendations for systematic adjuvant treatment such as radiotherapy. We studied a homogeneous series of grade II meningiomas treated by surgery in two university hospital centers to analyze use of radiotherapy and its efficacy. We retrospectively analyzed patients in our database with WHO grade II meningioma, operated on between 2007 and 2010 in the university hospitals of Montpellier and Bordeaux, France. Clinical and radiological data, treatments and survival were analyzed. Eighty-eight patients were included. Five-year overall survival was 89.7%. Nineteen patients received radiotherapy during follow-up, without significant impact on survival (P=0.27). In WHO grade II meningioma, it is currently difficult to establish clear recommendations for radiotherapy. The present study is in accordance with the literature...Continue Reading

References

Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·L K GoyalG H Barnett
Feb 1, 1957·Journal of Neurology, Neurosurgery, and Psychiatry·D SIMPSON
Mar 18, 2005·Neuropathology and Applied Neurobiology·J WillisD Everington
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jun 30, 2009·Journal of Neuro-oncology·Anne DurandJacques Guyotat
Aug 27, 2010·Journal of Neuro-oncology·Leland RogersMichael A Vogelbaum
Dec 3, 2013·Neurosurgical Focus·Kangmin D LeeChristopher M McPherson
Jun 16, 2015·Neuro-Chirurgie·S ZouaouiUNKNOWN Association des neuro-oncologues d’expression française (ANOCEF)
Jan 18, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Michael D JenkinsonMohsen Javadpour
Mar 30, 2016·Acta neurochirurgica·Charles Champeaux, Laurence Dunn
Jun 18, 2016·Journal of Neuro-oncology·Charles ChampeauxLewis Thorne
Sep 7, 2016·The Lancet Oncology·Roland GoldbrunnerMichael Weller
Sep 10, 2016·Journal of Neurosurgery·Hilary P BagshawDennis C Shrieve
Nov 18, 2016·Journal of Neuro-oncology·Amélie DarlixLuc Bauchet
Apr 30, 2017·World Neurosurgery·Christopher S GraffeoAditya Raghunathan
Jan 18, 2018·Expert Review of Neurotherapeutics·Caroline ApraMichel Kalamarides

❮ Previous
Next ❯

Citations

Jul 12, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P D Delgado-López, E M Corrales-García

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.